Antidiabetic Thiazolidinediones Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Rosiglitazone, Pioglitazone); End User (Hospital, Clinic, Others ), and Geography
Report Code: TIPRE00021679 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antidiabetic Thiazolidinediones Market - By Type
1.3.2 Antidiabetic Thiazolidinediones Market - By End User
1.3.3 Antidiabetic Thiazolidinediones Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIDIABETIC THIAZOLIDINEDIONES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIDIABETIC THIAZOLIDINEDIONES - GLOBAL MARKET OVERVIEW
6.2. ANTIDIABETIC THIAZOLIDINEDIONES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ROSIGLITAZONE
7.3.1. Overview
7.3.2. Rosiglitazone Market Forecast and Analysis
7.4. PIOGLITAZONE
7.4.1. Overview
7.4.2. Pioglitazone Market Forecast and Analysis
8. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ANTIDIABETIC THIAZOLIDINEDIONES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antidiabetic Thiazolidinediones Market Overview
9.1.2 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.1.3 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.1.4 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.1.5 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antidiabetic Thiazolidinediones Market
9.1.5.1.1 United States Antidiabetic Thiazolidinediones Market by Type
9.1.5.1.2 United States Antidiabetic Thiazolidinediones Market by End User
9.1.5.2 Canada Antidiabetic Thiazolidinediones Market
9.1.5.2.1 Canada Antidiabetic Thiazolidinediones Market by Type
9.1.5.2.2 Canada Antidiabetic Thiazolidinediones Market by End User
9.1.5.3 Mexico Antidiabetic Thiazolidinediones Market
9.1.5.3.1 Mexico Antidiabetic Thiazolidinediones Market by Type
9.1.5.3.2 Mexico Antidiabetic Thiazolidinediones Market by End User
9.2. EUROPE
9.2.1 Europe Antidiabetic Thiazolidinediones Market Overview
9.2.2 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.2.3 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.2.4 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.2.5 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antidiabetic Thiazolidinediones Market
9.2.5.1.1 Germany Antidiabetic Thiazolidinediones Market by Type
9.2.5.1.2 Germany Antidiabetic Thiazolidinediones Market by End User
9.2.5.2 France Antidiabetic Thiazolidinediones Market
9.2.5.2.1 France Antidiabetic Thiazolidinediones Market by Type
9.2.5.2.2 France Antidiabetic Thiazolidinediones Market by End User
9.2.5.3 Italy Antidiabetic Thiazolidinediones Market
9.2.5.3.1 Italy Antidiabetic Thiazolidinediones Market by Type
9.2.5.3.2 Italy Antidiabetic Thiazolidinediones Market by End User
9.2.5.4 Spain Antidiabetic Thiazolidinediones Market
9.2.5.4.1 Spain Antidiabetic Thiazolidinediones Market by Type
9.2.5.4.2 Spain Antidiabetic Thiazolidinediones Market by End User
9.2.5.5 United Kingdom Antidiabetic Thiazolidinediones Market
9.2.5.5.1 United Kingdom Antidiabetic Thiazolidinediones Market by Type
9.2.5.5.2 United Kingdom Antidiabetic Thiazolidinediones Market by End User
9.2.5.6 Rest of Europe Antidiabetic Thiazolidinediones Market
9.2.5.6.1 Rest of Europe Antidiabetic Thiazolidinediones Market by Type
9.2.5.6.2 Rest of Europe Antidiabetic Thiazolidinediones Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antidiabetic Thiazolidinediones Market Overview
9.3.2 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.3.3 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antidiabetic Thiazolidinediones Market
9.3.5.1.1 Australia Antidiabetic Thiazolidinediones Market by Type
9.3.5.1.2 Australia Antidiabetic Thiazolidinediones Market by End User
9.3.5.2 China Antidiabetic Thiazolidinediones Market
9.3.5.2.1 China Antidiabetic Thiazolidinediones Market by Type
9.3.5.2.2 China Antidiabetic Thiazolidinediones Market by End User
9.3.5.3 India Antidiabetic Thiazolidinediones Market
9.3.5.3.1 India Antidiabetic Thiazolidinediones Market by Type
9.3.5.3.2 India Antidiabetic Thiazolidinediones Market by End User
9.3.5.4 Japan Antidiabetic Thiazolidinediones Market
9.3.5.4.1 Japan Antidiabetic Thiazolidinediones Market by Type
9.3.5.4.2 Japan Antidiabetic Thiazolidinediones Market by End User
9.3.5.5 South Korea Antidiabetic Thiazolidinediones Market
9.3.5.5.1 South Korea Antidiabetic Thiazolidinediones Market by Type
9.3.5.5.2 South Korea Antidiabetic Thiazolidinediones Market by End User
9.3.5.6 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market
9.3.5.6.1 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market by Type
9.3.5.6.2 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antidiabetic Thiazolidinediones Market Overview
9.4.2 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.4.3 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antidiabetic Thiazolidinediones Market
9.4.5.1.1 South Africa Antidiabetic Thiazolidinediones Market by Type
9.4.5.1.2 South Africa Antidiabetic Thiazolidinediones Market by End User
9.4.5.2 Saudi Arabia Antidiabetic Thiazolidinediones Market
9.4.5.2.1 Saudi Arabia Antidiabetic Thiazolidinediones Market by Type
9.4.5.2.2 Saudi Arabia Antidiabetic Thiazolidinediones Market by End User
9.4.5.3 U.A.E Antidiabetic Thiazolidinediones Market
9.4.5.3.1 U.A.E Antidiabetic Thiazolidinediones Market by Type
9.4.5.3.2 U.A.E Antidiabetic Thiazolidinediones Market by End User
9.4.5.4 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market
9.4.5.4.1 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market by Type
9.4.5.4.2 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antidiabetic Thiazolidinediones Market Overview
9.5.2 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.5.3 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.5.4 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.5.5 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antidiabetic Thiazolidinediones Market
9.5.5.1.1 Brazil Antidiabetic Thiazolidinediones Market by Type
9.5.5.1.2 Brazil Antidiabetic Thiazolidinediones Market by End User
9.5.5.2 Argentina Antidiabetic Thiazolidinediones Market
9.5.5.2.1 Argentina Antidiabetic Thiazolidinediones Market by Type
9.5.5.2.2 Argentina Antidiabetic Thiazolidinediones Market by End User
9.5.5.3 Rest of South and Central America Antidiabetic Thiazolidinediones Market
9.5.5.3.1 Rest of South and Central America Antidiabetic Thiazolidinediones Market by Type
9.5.5.3.2 Rest of South and Central America Antidiabetic Thiazolidinediones Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIDIABETIC THIAZOLIDINEDIONES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIDIABETIC THIAZOLIDINEDIONES MARKET, KEY COMPANY PROFILES
12.1. BRISTOL-MYERS SQUIBB
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BOEHRINGER INGELHEIM
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVO NORDISK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antidiabetic Thiazolidinediones Market - By Type
1.3.2 Antidiabetic Thiazolidinediones Market - By End User
1.3.3 Antidiabetic Thiazolidinediones Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIDIABETIC THIAZOLIDINEDIONES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIDIABETIC THIAZOLIDINEDIONES - GLOBAL MARKET OVERVIEW
6.2. ANTIDIABETIC THIAZOLIDINEDIONES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ROSIGLITAZONE
7.3.1. Overview
7.3.2. Rosiglitazone Market Forecast and Analysis
7.4. PIOGLITAZONE
7.4.1. Overview
7.4.2. Pioglitazone Market Forecast and Analysis
8. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ANTIDIABETIC THIAZOLIDINEDIONES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antidiabetic Thiazolidinediones Market Overview
9.1.2 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.1.3 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.1.4 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.1.5 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antidiabetic Thiazolidinediones Market
9.1.5.1.1 United States Antidiabetic Thiazolidinediones Market by Type
9.1.5.1.2 United States Antidiabetic Thiazolidinediones Market by End User
9.1.5.2 Canada Antidiabetic Thiazolidinediones Market
9.1.5.2.1 Canada Antidiabetic Thiazolidinediones Market by Type
9.1.5.2.2 Canada Antidiabetic Thiazolidinediones Market by End User
9.1.5.3 Mexico Antidiabetic Thiazolidinediones Market
9.1.5.3.1 Mexico Antidiabetic Thiazolidinediones Market by Type
9.1.5.3.2 Mexico Antidiabetic Thiazolidinediones Market by End User
9.2. EUROPE
9.2.1 Europe Antidiabetic Thiazolidinediones Market Overview
9.2.2 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.2.3 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.2.4 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.2.5 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antidiabetic Thiazolidinediones Market
9.2.5.1.1 Germany Antidiabetic Thiazolidinediones Market by Type
9.2.5.1.2 Germany Antidiabetic Thiazolidinediones Market by End User
9.2.5.2 France Antidiabetic Thiazolidinediones Market
9.2.5.2.1 France Antidiabetic Thiazolidinediones Market by Type
9.2.5.2.2 France Antidiabetic Thiazolidinediones Market by End User
9.2.5.3 Italy Antidiabetic Thiazolidinediones Market
9.2.5.3.1 Italy Antidiabetic Thiazolidinediones Market by Type
9.2.5.3.2 Italy Antidiabetic Thiazolidinediones Market by End User
9.2.5.4 Spain Antidiabetic Thiazolidinediones Market
9.2.5.4.1 Spain Antidiabetic Thiazolidinediones Market by Type
9.2.5.4.2 Spain Antidiabetic Thiazolidinediones Market by End User
9.2.5.5 United Kingdom Antidiabetic Thiazolidinediones Market
9.2.5.5.1 United Kingdom Antidiabetic Thiazolidinediones Market by Type
9.2.5.5.2 United Kingdom Antidiabetic Thiazolidinediones Market by End User
9.2.5.6 Rest of Europe Antidiabetic Thiazolidinediones Market
9.2.5.6.1 Rest of Europe Antidiabetic Thiazolidinediones Market by Type
9.2.5.6.2 Rest of Europe Antidiabetic Thiazolidinediones Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antidiabetic Thiazolidinediones Market Overview
9.3.2 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.3.3 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antidiabetic Thiazolidinediones Market
9.3.5.1.1 Australia Antidiabetic Thiazolidinediones Market by Type
9.3.5.1.2 Australia Antidiabetic Thiazolidinediones Market by End User
9.3.5.2 China Antidiabetic Thiazolidinediones Market
9.3.5.2.1 China Antidiabetic Thiazolidinediones Market by Type
9.3.5.2.2 China Antidiabetic Thiazolidinediones Market by End User
9.3.5.3 India Antidiabetic Thiazolidinediones Market
9.3.5.3.1 India Antidiabetic Thiazolidinediones Market by Type
9.3.5.3.2 India Antidiabetic Thiazolidinediones Market by End User
9.3.5.4 Japan Antidiabetic Thiazolidinediones Market
9.3.5.4.1 Japan Antidiabetic Thiazolidinediones Market by Type
9.3.5.4.2 Japan Antidiabetic Thiazolidinediones Market by End User
9.3.5.5 South Korea Antidiabetic Thiazolidinediones Market
9.3.5.5.1 South Korea Antidiabetic Thiazolidinediones Market by Type
9.3.5.5.2 South Korea Antidiabetic Thiazolidinediones Market by End User
9.3.5.6 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market
9.3.5.6.1 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market by Type
9.3.5.6.2 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antidiabetic Thiazolidinediones Market Overview
9.4.2 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.4.3 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antidiabetic Thiazolidinediones Market
9.4.5.1.1 South Africa Antidiabetic Thiazolidinediones Market by Type
9.4.5.1.2 South Africa Antidiabetic Thiazolidinediones Market by End User
9.4.5.2 Saudi Arabia Antidiabetic Thiazolidinediones Market
9.4.5.2.1 Saudi Arabia Antidiabetic Thiazolidinediones Market by Type
9.4.5.2.2 Saudi Arabia Antidiabetic Thiazolidinediones Market by End User
9.4.5.3 U.A.E Antidiabetic Thiazolidinediones Market
9.4.5.3.1 U.A.E Antidiabetic Thiazolidinediones Market by Type
9.4.5.3.2 U.A.E Antidiabetic Thiazolidinediones Market by End User
9.4.5.4 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market
9.4.5.4.1 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market by Type
9.4.5.4.2 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antidiabetic Thiazolidinediones Market Overview
9.5.2 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.5.3 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.5.4 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.5.5 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antidiabetic Thiazolidinediones Market
9.5.5.1.1 Brazil Antidiabetic Thiazolidinediones Market by Type
9.5.5.1.2 Brazil Antidiabetic Thiazolidinediones Market by End User
9.5.5.2 Argentina Antidiabetic Thiazolidinediones Market
9.5.5.2.1 Argentina Antidiabetic Thiazolidinediones Market by Type
9.5.5.2.2 Argentina Antidiabetic Thiazolidinediones Market by End User
9.5.5.3 Rest of South and Central America Antidiabetic Thiazolidinediones Market
9.5.5.3.1 Rest of South and Central America Antidiabetic Thiazolidinediones Market by Type
9.5.5.3.2 Rest of South and Central America Antidiabetic Thiazolidinediones Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIDIABETIC THIAZOLIDINEDIONES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIDIABETIC THIAZOLIDINEDIONES MARKET, KEY COMPANY PROFILES
12.1. BRISTOL-MYERS SQUIBB
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BOEHRINGER INGELHEIM
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVO NORDISK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Bristol-Myers Squibb
2. Pfizer
3. Boehringer Ingelheim
4. Eli Lilly
5. Merck and Co.
6. AstraZeneca
7. GlaxoSmithKline
8. Sanofi
9. Takeda Pharmaceuticals
10. Novo Nordisk
11. Mylan Pharmaceuticals Inc.
12. Teva Pharmaceuticals USA, Inc.
13. Aurobindo Pharma Limited
14. Solco Healthcare U.S., LLC
15. Macleods Pharmaceuticals Limited
16. PuraCap Pharmaceutical LLC
1. Bristol-Myers Squibb
2. Pfizer
3. Boehringer Ingelheim
4. Eli Lilly
5. Merck and Co.
6. AstraZeneca
7. GlaxoSmithKline
8. Sanofi
9. Takeda Pharmaceuticals
10. Novo Nordisk
11. Mylan Pharmaceuticals Inc.
12. Teva Pharmaceuticals USA, Inc.
13. Aurobindo Pharma Limited
14. Solco Healthcare U.S., LLC
15. Macleods Pharmaceuticals Limited
16. PuraCap Pharmaceutical LLC
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount